ARQT (STOCKS)
Arcutis Biotherapeutics, Inc. Common Stock
$25.830000
-0.450000 (-1.71%)
Prev close: $26.280000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Todd Franklin Watanabe
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,289.18M
- Employees
- 342
- P/E (TTM)
- 126.90
- P/B (TTM)
- 14.96
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.11 | $0.04 | +0.0661 | +150.57% |
|
Mar 2026 (Q1)
|
$-0.09 | $-0.08 | -0.0062 | -7.40% |
|
Dec 2025 (Q4)
|
$0.13 | $0.12 | +0.0143 | +12.36% |
|
Sep 2025 (Q3)
|
$0.06 | $-0.10 | +0.1619 | +158.88% |
Financial Statements
| Revenues | $463.98M |
| Benefits Costs and Expenses | $429.73M |
| Cost Of Revenue | $41.10M |
| Costs And Expenses | $429.73M |
| Gross Profit | $422.89M |
| Operating Expenses | $388.63M |
| Selling, General, and Administrative Expenses | $297.60M |
| Research and Development | $91.04M |
| Operating Income/Loss | $34.25M |
| Income/Loss From Continuing Operations After Tax | $28.52M |
| Income/Loss From Continuing Operations Before Tax | $34.25M |
| Income Tax Expense/Benefit | $779.00K |
| Net Income/Loss | $28.52M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $28.52M |
| Net Income/Loss Available To Common Stockholders, Basic | $28.52M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.22 |
| Diluted Earnings Per Share | $0.22 |
| Basic Average Shares | 257,914,000 |
| Diluted Average Shares | 269,179,000 |
| Assets | $488.54M |
| Current Assets | $467.67M |
| Inventory | $38.88M |
| Other Current Assets | $428.79M |
| Noncurrent Assets | $20.87M |
| Fixed Assets | $872.00K |
| Intangible Assets | $13.69M |
| Other Non-current Assets | $6.31M |
| Liabilities | $267.96M |
| Current Liabilities | $160.34M |
| Accounts Payable | $6.60M |
| Wages | $15.51M |
| Other Current Liabilities | $138.23M |
| Noncurrent Liabilities | $107.62M |
| Long-term Debt | $108.90M |
| Equity | $220.58M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $220.58M |
| Liabilities And Equity | $488.54M |
| Net Cash Flow From Operating Activities | $39.31M |
| Net Cash Flow From Operating Activities, Continuing | $39.31M |
| Net Cash Flow From Investing Activities | -$85.98M |
| Net Cash Flow From Investing Activities, Continuing | -$85.98M |
| Net Cash Flow From Financing Activities | $8.26M |
| Net Cash Flow From Financing Activities, Continuing | $8.26M |
| Net Cash Flow | -$38.42M |
| Net Cash Flow, Continuing | -$38.42M |
| Comprehensive Income/Loss | $27.90M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $27.90M |
| Other Comprehensive Income/Loss | $27.90M |
| Other Comprehensive Income/Loss Attributable To Parent | -$621.00K |